Meena Bedi, MD

Publications

• Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma.

  (Bedi M, Singh R, Charlson JA, Kelly T, Johnstone C, Wooldridge A, Hackbarth DA, Moore N, Neilson JC, King DM.) Adv Radiat Oncol. 2022 May-Jun;7(3):100850 PMID: 35647402 PMCID: PMC9133395 06/02/2022

• Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms.

  (Squires MH, Ethun CG, Donahue EE, Benbow JH, Anderson CJ, Jagosky MH, Manandhar M, Patt JC, Kneisl JS, Salo JC, Hill JS, Ahrens W, Prabhu RS, Livingston MB, Gower NL, Needham M, Trufan SJ, Fields RC, Krasnick BA, Bedi M, Votanopoulos K, Chouliaras K, Grignol V, Roggin KK, Tseng J, Poultsides G, Tran TB, Cardona K, Howard JH.) Ann Surg Oncol. 2022 May;29(5):3291-3301 PMID: 35015183 01/12/2022

• Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer.

  (Ponce SEB, Erickson BA, Hall WA, Bedi M, Martens MJ, Siker M, Thomas J, George B, Ludwig K, Peterson C, Ridolfi T, Longo JM.) J Gastrointest Oncol. 2022 Feb;13(1):185-196 PMID: 35284138 PMCID: PMC8899735 03/15/2022

• Dosimetric predictors of local control and complications in gynecologic transperineal implant patients: The medical college of wisconsin experience.

  (Zeitlin R, Yu G, Wheatley M, Morrow N, Rownd J, Rein L, Banerjee A, Bedi M, Erickson B.) Brachytherapy. 2022 Jan-Feb;21(1):94-109 PMID: 34937684 SCOPUS ID: 2-s2.0-85121459405 12/24/2021

• Preoperative Radiation Performed at a Nonsarcoma Center May Lead to Increased Wound Complications Following Resection in Patients With Soft Tissue Sarcomas.

  (Ellison C, King DM, Neilson JC, Wooldridge A, Charlson JA, Hackbarth DA, Johnstone C, Bedi M.) Am J Clin Oncol. 2021 12 01;44(12):619-623 PMID: 34753886 SCOPUS ID: 2-s2.0-85120362291 11/11/2021

• A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma Collaborative.

  (Lee RM, Ethun CG, Gamboa AC, Turgeon MK, Tran T, Poultsides G, Grignol V, Bedi M, Mogal H, Clarke CN, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Oskouei SV, Monson DK, Reimer NB, Maithel SK, Pickens A, Cardona K.) J Surg Oncol. 2021 Dec;124(8):1477-1484 PMID: 34374088 PMCID: PMC8595861 SCOPUS ID: 2-s2.0-85112074442 08/11/2021

• Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial.

  (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF.) Pract Radiat Oncol. 2021 Nov-Dec;11(6):527-533 PMID: 33848618 PMCID: PMC8638529 SCOPUS ID: 2-s2.0-85107984420 04/14/2021

• Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the Extremity.

  (Olson CR, Suarez-Kelly LP, Ethun CG, Shelby RD, Yu PY, Hughes TM, Palettas M, Tran TB, Poultsides G, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, King DM, Bedi M, Pollock RE, Grignol VP, Cardona K, Howard JH.) Am Surg. 2021 Nov;87(11):1752-1759 PMID: 34758653 SCOPUS ID: 2-s2.0-85119115004 11/12/2021

• Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline.

  (Salerno KE, Alektiar KM, Baldini EH, Bedi M, Bishop AJ, Bradfield L, Chung P, DeLaney TF, Folpe A, Kane JM, Li XA, Petersen I, Powell J, Stolten M, Thorpe S, Trent JC, Voermans M, Guadagnolo BA.) Pract Radiat Oncol. 2021 Sep-Oct;11(5):339-351 PMID: 34326023 SCOPUS ID: 2-s2.0-85113560673 07/31/2021

• A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.

  (Squires MH, Ethun CG, Donahue EE, Benbow JH, Anderson CJ, Jagosky MH, Salo JC, Hill JS, Ahrens W, Prabhu RS, Livingston MB, Gower NL, Needham M, Trufan SJ, Fields RC, Krasnick BA, Bedi M, Abbott DE, Schwartz P, Votanopoulos K, Chouliaras K, Grignol V, Roggin KK, Tseng J, Poultsides G, Tran TB, Cardona K, Howard JH.) J Surg Oncol. 2021 Oct;124(5):829-837 PMID: 34254691 07/14/2021

• Risk-Adapted Radiation Deintensification in Children and Young Adults With Soft Tissue Sarcoma: New Questions Arise and Prior Questions Resurface.

  (Indelicato DJ, Bedi M.) Int J Radiat Oncol Biol Phys. 2021 07 01;110(3):831-832 PMID: 34089681 06/06/2021

• Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma.

  (Valle LF, Bernthal N, Eilber FC, Shabason JE, Bedi M, Kalbasi A.) Sarcoma. 2021;2021:3735874 PMID: 34720663 PMCID: PMC8556117 11/02/2021